{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:24:32Z","timestamp":1784903072929,"version":"3.55.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2021209004"],"award-info":[{"award-number":["H2021209004"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy with an extremely poor prognosis. Gemcitabine (GEM), the standard first-line chemotherapeutic agent for PDAC, often fails due to the development of drug resistance. This study aims to systematically investigate the mechanisms underlying gemcitabine resistance in PDAC and identify novel therapeutic targets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated multi-omics data, including microarray, transcriptomic, proteomic, single-cell RNA sequencing, and spatial transcriptomic datasets. Machine learning algorithms were employed to screen for key genes associated with resistance. The correlation between candidate genes and drug-resistant phenotypes was inferred using pancreatic cancer cell lines, mouse models, and clinical patient data. Functional and mechanistic studies were subsequently conducted through in vitro cellular experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our findings identify the prion protein gene (\n                      <jats:italic>PRNP<\/jats:italic>\n                      ) as a key gene associated with chemoresistance.\n                      <jats:italic>PRNP<\/jats:italic>\n                      expression is significantly elevated in PDAC patients treated with gemcitabine and correlates with the resistant phenotype. Cellular experiments confirmed that gemcitabine exposure upregulates PRNP expression, while\n                      <jats:italic>PRNP<\/jats:italic>\n                      knockdown significantly reduces the half-maximal inhibitory concentration of gemcitabine and enhances its cytotoxicity. Mechanistic studies demonstrate that\n                      <jats:italic>PRNP<\/jats:italic>\n                      drives resistance through dual pathways: it promotes epithelial-mesenchymal transition (EMT), enhancing cellular invasiveness, and suppresses ferroptosis by upregulating the expression of ferroptosis-related proteins SLC7A11 and GPX4, thereby maintaining redox homeostasis. Further single-cell and spatial transcriptomic analyses revealed that PRNP is predominantly enriched in a specific subset of cancer-associated fibroblasts (CAFs) following chemotherapy, which is associated with the establishment of an immunosuppressive tumor microenvironment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      This study demonstrates that\n                      <jats:italic>PRNP<\/jats:italic>\n                      is a key regulator of gemcitabine resistance in PDAC, modulating EMT, ferroptosis, and the tumor immune microenvironment. Targeting\n                      <jats:italic>PRNP<\/jats:italic>\n                      represents a promising therapeutic strategy to reverse gemcitabine resistance and may hold significant potential for clinical translation in PDAC treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1667835","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:30:53Z","timestamp":1764225053000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrated multi-omics elucidates PRNP knockdown-mediated chemosensitization to gemcitabine in pancreatic ductal adenocarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Bing","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liumeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanrui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2014.462","article-title":"Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic Malignancies","volume":"111","author":"Roy","year":"2014","journal-title":"Br J Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.50756","article-title":"NALIRIFOX, FOLFIRINOX, and gemcitabine with nab-paclitaxel as first-line chemotherapy for metastatic pancreatic cancer: A systematic review and meta-analysis","volume":"7","author":"Nichetti","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.16199","article-title":"Comparison of FOLFIRINOX vs gemcitabine plus nab-paclitaxel as first-line chemotherapy for metastatic pancreatic ductal adenocarcinoma","volume":"5","author":"Klein-Brill","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2014.00056","article-title":"Role of the prion protein family in the gonads","volume":"2","author":"Allais-Bonnet","year":"2014","journal-title":"Front Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.7150\/jca.14237","article-title":"The role of prion protein expression in predicting gastric cancer prognosis","volume":"7","author":"Tang","year":"2016","journal-title":"J Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.3390\/ijms20205107","article-title":"Prion protein in glioblastoma multiforme","volume":"20","author":"Ryskalin","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/bcr3398","article-title":"Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer","volume":"15","author":"Dery","year":"2013","journal-title":"Breast Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.3390\/cancers14133173","article-title":"High expression of PRNP predicts poor prognosis in Korean patients with gastric cancer","volume":"14","author":"Choi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3205040","article-title":"Downregulated PRNP facilitates cell proliferation and invasion and has effect on the immune regulation in ovarian cancer","volume":"2022","author":"Hu","year":"2022","journal-title":"J Immunol Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2005.06.007","article-title":"Absence of mutations in the prion-protein gene in a large cohort of HMSN patients","volume":"15","author":"Koop","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"B14","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1038\/s41467-023-40314-w","article-title":"Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment","volume":"14","author":"Xue","year":"2023","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12967-024-05164-0","article-title":"Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer","volume":"22","author":"Mouillet-Richard","year":"2024","journal-title":"J Transl Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03130-0","article-title":"PrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up","volume":"43","author":"Lailler","year":"2024","journal-title":"Oncogene"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12188","article-title":"Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma","volume":"41","author":"Li","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2200143119","article-title":"Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer","volume":"119","author":"Principe","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.743908","article-title":"Clinical impact of molecular subtyping of pancreatic cancer","volume":"9","author":"Zhou","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41467-023-36296-4","article-title":"Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment","volume":"14","author":"Werba","year":"2023","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2022.100409","article-title":"Comparative proteomic analysis identifies key metabolic regulators of gemcitabine resistance in pancreatic cancer","volume":"21","author":"Lin","year":"2022","journal-title":"Mol Cell Proteomics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3975","article-title":"Integrative genomic analysis of gemcitabine resistance in pancreatic cancer by patient-derived xenograft models","volume":"27","author":"Yang","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S1470-2045(10)70244-8","article-title":"The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer","volume":"12","author":"Jordheim","year":"2011","journal-title":"Lancet Oncol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0048146","article-title":"Silencing prion protein in MDA-MB-435 breast cancer cells leads to pleiotropic cellular responses to cytotoxic stimuli","volume":"7","author":"Yu","year":"2012","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.3390\/biomedicines10112833","article-title":"Cellular prion protein role in cancer biology: is it A potential therapeutic target","volume":"10","author":"Yousaf","year":"2022","journal-title":"Biomedicines"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1391873","article-title":"PRNP is a pan-cancer prognostic and immunity-related to EMT in colorectal cancer","volume":"12","author":"Chen","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288091","article-title":"Copper homeostasis-associated gene PRNP regulates ferroptosis and immune infiltration in breast cancer","volume":"18","author":"Lin","year":"2023","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"6292","DOI":"10.1038\/s41467-022-33991-6","article-title":"PD-L1-directed PlGF\/VEGF blockade synergizes with chemotherapy by targeting CD141(+) cancer-associated fibroblasts in pancreatic cancer","volume":"13","author":"Kim","year":"2022","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2023.09.021","article-title":"BRD9-SMAD2\/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma","volume":"166","author":"Feng","year":"2024","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-2012-0256","article-title":"Association of prion protein expression with pancreatic adenocarcinoma survival in the SEER residual tissue repository","volume":"10","author":"Sy","year":"2011","journal-title":"Cancer biomark"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1016\/j.cell.2021.07.020","article-title":"Targeting Pin1 renders pancreatic cancer eradicable by synergizing with immunochemotherapy","volume":"184","author":"Koikawa","year":"2021","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1536428","article-title":"Gemcitabine: immunomodulatory or immunosuppressive role in the tumor microenvironment","volume":"16","author":"Nemati","year":"2025","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.12.7254","article-title":"Functional implication of cellular prion protein in antigen-driven interactions between T cells and dendritic cells","volume":"176","author":"Ballerini","year":"2006","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1940674","DOI":"10.1080\/2162402x.2021.1940674","article-title":"Prognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype","volume":"10","author":"Ghazi","year":"2021","journal-title":"OncoImmunology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2016.07.010","article-title":"Cellular prion protein mediates pancreatic cancer cell survival and invasion through association with and enhanced signaling of Notch1","volume":"186","author":"Wang","year":"2016","journal-title":"Am J Pathol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.pan.2020.08.004","article-title":"The occurrence of prion protein in surgically resected pancreatic adenocarcinoma","volume":"20","author":"Bianchini","year":"2020","journal-title":"Pancreatology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i42.7324","article-title":"Detailing the ultrastructure\u2019s increase of prion protein in pancreatic adenocarcinoma","volume":"27","author":"Bianchini","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124092","article-title":"Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer","volume":"5","author":"Wiegmans","year":"2019","journal-title":"JCI Insight"},{"key":"B39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13073-024-01287-7","article-title":"Integrative analysis of spatial and single-cell transcriptome data from human pancreatic cancer reveals an intermediate cancer cell population associated with poor prognosis","volume":"16","author":"Kim","year":"2024","journal-title":"Genome Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101234","article-title":"Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-response","volume":"4","author":"Tang","year":"2023","journal-title":"Cell Rep Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41419-019-2116-x","article-title":"Schwann cells support oncogenic potential of pancreatic cancer cells through TGFbeta signaling","volume":"10","author":"Roger","year":"2019","journal-title":"Cell Death Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200089","article-title":"The role of Schwann cells in cancer","volume":"6","author":"Deborde","year":"2022","journal-title":"Adv Biol (Weinh)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"dju184","DOI":"10.1093\/jnci\/dju184","article-title":"Investigation of Schwann cells at neoplastic cell sites before the onset of cancer invasion","volume":"106","author":"Demir","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25300","article-title":"Schwann cells increase prostate and pancreatic tumor cell invasion using laminin binding A6 integrin","volume":"117","author":"Sroka","year":"2016","journal-title":"J Cell Biochem"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39542","article-title":"Binding of pro-prion to filamin A disrupts cytoskeleton and correlates with poor prognosis in pancreatic cancer","volume":"119","author":"Li","year":"2009","journal-title":"J Clin Invest"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.962742","article-title":"Single-cell transcriptomics uncover the key ferroptosis regulators contribute to cancer progression in head and neck squamous cell carcinoma","volume":"9","author":"Liu","year":"2022","journal-title":"Front Mol Biosci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.010","article-title":"Dual role of cellular prion protein in normal host and Alzheimer\u2019s disease","volume":"93","author":"Onodera","year":"2017","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00207","article-title":"Deficiency of prion protein induces impaired autophagic flux in neurons","volume":"6","author":"Shin","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23647","article-title":"Inhibition of the RBMS1\/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer","volume":"63","author":"Xu","year":"2023","journal-title":"Mol Carcinogenesis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3390\/ijms24021405","article-title":"The role of cellular prion protein in glioma tumorigenesis could be through the autophagic mechanisms: A narrative review","volume":"24","author":"Armocida","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1226735","article-title":"PRNP\/prion protein regulates the secretion of exosomes modulating CAV1\/caveolin-1-suppressed autophagy","volume":"12","author":"Dias","year":"2016","journal-title":"Autophagy"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4161\/auto.21164","article-title":"Oxidative stress impairs autophagic flux in prion protein-deficient hippocampal cells","volume":"8","author":"Oh","year":"2012","journal-title":"Autophagy"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1002\/jor.22034","article-title":"Prion proteins (PRNP and PRND) are over-expressed in osteosarcoma","volume":"30","author":"Sollazzo","year":"2012","journal-title":"J Orthop Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.09.068","article-title":"Tumor necrosis factor attenuates prion protein-deficient neuronal cell death by increases in anti-apoptotic Bcl-2 family proteins","volume":"310","author":"Sakudo","year":"2003","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667835\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:30:55Z","timestamp":1764225055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1667835\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2025.1667835"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1667835","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"article-number":"1667835"}}